Author: Novarum DX
Novarum DX™ is set to showcase how to read and share the results of diagnostic tests using a smartphone, during the week of the American Association for Clinical Chemistry (AACC) annual meeting in San Diego.
The free breakfast seminar is not part of the official AACC programme, but it complements the conference theme of innovative clinical lab technologies, whilst providing professionals from the global medical industry with the opportunity to learn more about technologies for next generation diagnostics.
Novarum™, acquired by BBI Group™ in October 2016, will showcase their unique smartphone reader technology, which enables the results of diagnostic tests to be accurately read at the point of care. The intuitive mobile app allows patients to share test results securely, with healthcare professionals and minimal end-user training.
Dr. Niall McLaren, Business Development Manager at Novarum DX™, commented:
“We’re delighted to be holding this breakfast seminar on technologies for next generation diagnostics. Novarum’s custom apps are used by established diagnostic companies and we also work with smaller, more nimble specialists to develop original approaches to monitor infectious disease, toxicology and auto-immune disease.
Novarum’s technology has the potential to deliver a step-change in traditional diagnostic processes using a smartphone, and we look forward to welcoming delegates to an informative session, which will also deliver great networking opportunities.”
The seminar will also provide delegates with the opportunity to learn more about BBI Solutions’ innovative Morffi™ Signal Enhancement Technology. Developed by BBI scientists in-house, the novel conjugation technology improves assay performance and has proven to increase the sensitivity, as well as achieve a faster time to result in lateral flow assays.
If you are attending AACC, there is an opportunity to meet representatives from Novarum™ and BBI Solutions™ at stand no. 1539.